source
- FDA Requests Public Feedback on Designing Early-Phase Trials for Psychedelic Drug IbogaineThe U.S. Food and Drug Administration announced it is seeking comments from the public on how to structure early-phase clinical studies of ibogaine, a plant-derived psychoactive compound. The agen…
- FDA issues request for information on early-phase ibogaine trial designThe FDA announced a request for information (RFI) to gather input on how to design early-phase clinical trials of ibogaine drug products. The agency is looking for comments on protocol elements su…